Gaithersburg cell modification technology firm MaxCyte Inc. is expected to go public on the London Stock Exchange Tuesday morning.
MaxCyte, which will trade under the ticker symbol MXCT, is seeking to raise between $14 million and $15 million, said CEO and President Doug Doerfler.
{iframe}http://www.bizjournals.com/washington/morning_call/2016/03/maxcyte-goes-public-on-london-stock-exchange.html?ana=e_wash_rdup&s=newsletter&ed=2016-03-29&u=wjGEy67ABoSnsLErlc5ry0j5hx3&t=1459283579&j=71825182{/iframe}